TROMAX-500

TROMAX-500 contains Tranexamic Acid 500 mg in an oral tablet formulation. It belongs to the antifibrinolytic class of pharmaceutical agents and is presented as a defined-strength formulation for professional pharmaceutical supply. Each tablet contains 500 mg of Tranexamic Acid, with the product identified by its active ingredient, strength and tablet dosage form.

Tranexamic Acid 500 mg tablets are included in pharmaceutical portfolios serving hospitals, pharmacies, medical institutions and healthcare professionals. The formulation can be catalogued by its generic composition, strength, dosage form and brand name to support accurate product identification, inventory management and procurement processes.

TROMAX-500 is supplied in a carton containing 10 strips of 10 tablets, providing a total pack size of 100 tablets. Its standardised product details support clear documentation across pharmaceutical product listings and institutional purchasing systems. For healthcare procurement teams, maintaining consistent product information—including brand, active ingredient, strength and pack configuration—is important for reliable catalogue management.